Risperidone Treatment in Schizophrenia Patients Who Are Currently Taking Clozapine
Status:
Completed
Trial end date:
2007-12-01
Target enrollment:
Participant gender:
Summary
This study will determine whether adding the drug risperidone (Risperdal®) is more effective
than placebo in treating schizophrenic patients who are taking the drug clozapine.
Phase:
Phase 4
Details
Lead Sponsor:
University of Maryland University of Maryland, Baltimore
Collaborators:
National Institute of Mental Health (NIMH) Ortho-McNeil Janssen Scientific Affairs, LLC